Recovery Of Ocular Events With Longer-Term Follow-Up In The Dreammm-2 Study Of Single-Agent Belantamab Mafodotin (Belamaf) In Patients With Relapsed Or Refractory Multiple Myeloma (Rrmm)Sagar Lonial,Ajay Nooka,Praneetha Thulasi,Ashraf Z. Badros,Bennie H. Jeng,Natalie S. Callander,Douglas Sborov,Brian E. Zaugg,Rakesh Popat,Simona Degli Esposti,Julie Byrne,Joanna Opalinska,January Baron,Trisha Piontek,Ira Gupta,Reza Dana,Asim Farooq,Andrzej JakubowiakBLOOD（2020）引用 9|浏览27暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
